Therapeutic targeting of the DNA damage mediators CHK1 and Wee1 in neuroblastoma

被引：0
|
作者：
Russell, Mike [1 ]
Levin, Kirill [1 ]
Rader, JulieAnn [1 ]
Toniatti, Carlo [2 ]
Maris, John M. [1 ]
Cole, Kristina A. [1 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Merck Res Labs, Boston, MA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1436
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1436
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma
    Russell, Mike R.
    Levin, Kirill
    Rader, JulieAnn
    Belcastro, Lili
    Li, Yimei
    Martinez, Daniel
    Pawel, Bruce
    Shumway, Stuart D.
    Maris, John M.
    Cole, Kristina A.
    CANCER RESEARCH, 2013, 73 (02) : 776 - 784
  • [2] Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma
    Bruyer, Angelique
    Dutrieux, Laure
    de Boussac, Hugues
    Martin, Thibaut
    Chemlal, Djamila
    Robert, Nicolas
    Requirand, Guilhem
    Cartron, Guillaume
    Vincent, Laure
    Herbaux, Charles
    Lutzmann, Malik
    Bret, Caroline
    Pasero, Philippe
    Moreaux, Jerome
    Ovejero, Sara
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Inhibition of Chk1 and Wee1 as a new therapeutic approach in Mantle Cell Lymphoma
    Carrassa, Laura
    Chila, Rosaria
    Basana, Alessandra
    Ricci, Francesca
    Guffanti, Federica
    Lupi, Monica
    Rinaldi, Andrea
    Cascione, Luciano
    Bertoni, Francesco
    Broggini, Massimo
    Damia, Giovanna
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
    Chila, Rosaria
    Basana, Alessandra
    Lupi, Monica
    Guffanti, Federica
    Gaudio, Eugenio
    Rinaldi, Andrea
    Cascione, Luciano
    Restelli, Valentina
    Tarantelli, Chiara
    Bertoni, Francesco
    Damia, Giovanna
    Carrassa, Laura
    ONCOTARGET, 2015, 6 (05) : 3394 - 3408
  • [5] Combined inhibition of Chk1 and Wee1 kinases for cancer treatment
    Hauge, S.
    Hasvold, G.
    Joel, M.
    Naucke, C.
    Rodland, G. E.
    Syljuasen, R. G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S478 - S478
  • [6] Chk1 and Wee1 kinases coordinate DNA replication, chromosome condensation, and anaphase entry
    Fasulo, Barbara
    Koyama, Carol
    Yu, Kristina R.
    Homola, Ellen M.
    Hsieh, Tao S.
    Campbell, Shelagh D.
    Sullivan, William
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23 (06) : 1047 - 1057
  • [7] Characterizing functional DNA damage and response caused by the combination of CHK1 and WEE1 inhibitors in ovarian and breast cancer models
    Adam Stewart
    Jiin Song
    Lisa Pickard
    Giovanna Muggiolu
    Sylvie Sauvaigo
    Alexis De Haven Brandon
    Florence Raynaud
    Udai Banerji
    BJC Reports, 2 (1):
  • [8] Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
    Di Rora, Andrea Ghelli Luserna
    Bocconcelli, Matteo
    Ferrari, Anna
    Terragna, Carolina
    Bruno, Samantha
    Imbrogno, Enrica
    Beeharry, Neil
    Robustelli, Valentina
    Ghetti, Martina
    Napolitano, Roberta
    Chirumbolo, Gabriella
    Marconi, Giovanni
    Papayannidis, Cristina
    Paolini, Stefania
    Sartor, Chiara
    Simonetti, Giorgia
    Yen, Timothy J.
    Martinelli, Giovanni
    CANCERS, 2019, 11 (11)
  • [9] Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation
    Davies, Kurtis D.
    Cable, P. LouAnn
    Garrus, Jennifer E.
    Sullivan, Francis X.
    von Carlowitz, Ira
    Le Huerou, Yvan
    Wallace, Eli
    Woessner, Richard D.
    Gross, Stefan
    CANCER BIOLOGY & THERAPY, 2011, 12 (09) : 788 - 796
  • [10] Positive regulation of Wee1 by Chk1 and 14-3-3 proteins
    Lee, J
    Kumagai, A
    Dunphy, WG
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (03) : 551 - 563
12345